A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Calusterone
Rilmenidine
The risk or severity of Tachycardia can be increased when Rilmenidine is combined with Nabiximols.
Calusterone
Etafedrine
The risk or severity of Tachycardia can be increased when Etafedrine is combined with Nabiximols.
Calusterone
Ractopamine
The risk or severity of Tachycardia can be increased when Ractopamine is combined with Nabiximols.
Calusterone
Amitraz
The risk or severity of Tachycardia can be increased when Amitraz is combined with Nabiximols.
Calusterone
DL-Methylephedrine
The risk or severity of Tachycardia can be increased when DL-Methylephedrine is combined with Nabiximols.
Calusterone
Moxonidine
The risk or severity of Tachycardia can be increased when Moxonidine is combined with Nabiximols.
Calusterone
Cirazoline
The risk or severity of Tachycardia can be increased when Cirazoline is combined with Nabiximols.
Calusterone
Hexoprenaline
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Nabiximols.
Calusterone
Adrafinil
The risk or severity of Tachycardia can be increased when Adrafinil is combined with Nabiximols.
Calusterone
Protokylol
The risk or severity of Tachycardia can be increased when Protokylol is combined with Nabiximols.
Calusterone
Naphazoline
The risk or severity of Tachycardia can be increased when Naphazoline is combined with Nabiximols.
Calusterone
Levonordefrin
The risk or severity of Tachycardia can be increased when Levonordefrin is combined with Nabiximols.
Calusterone
Isometheptene
The risk or severity of Tachycardia can be increased when Isometheptene is combined with Nabiximols.
Calusterone
Xylometazoline
The risk or severity of Tachycardia can be increased when Xylometazoline is combined with Nabiximols.
Calusterone
Solabegron
The risk or severity of Tachycardia can be increased when Solabegron is combined with Nabiximols.
Calusterone
Amibegron
The risk or severity of Tachycardia can be increased when Amibegron is combined with Nabiximols.
Calusterone
SLV319
The risk or severity of Tachycardia can be increased when SLV319 is combined with Nabiximols.
Calusterone
Phendimetrazine
The risk or severity of Tachycardia can be increased when Phendimetrazine is combined with Nabiximols.
Calusterone
Emapalumab
The metabolism of Nabiximols can be increased when combined with Emapalumab.
Calusterone
Siltuximab
The metabolism of Nabiximols can be increased when combined with Siltuximab.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3